Duplicate Document
This document appears to be a copy. The original version is:
EFTA Document EFTA01493897Case File
efta-efta01493897DOJ Data Set 10CorrespondenceEFTA Document EFTA01493897
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01493897
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
FINANCIAL TRUST COMPANY INC ACCT.
For the Period 2/1/13 to 2/28/13
Note:
P indicates position adjusted for Pending Trade Activity.
Unrealized Gain/Loss is shown as "N/A" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P. Morgan team for additional
information.
Equity Detail
Price
Quantity
Value
Adjusted Tax Cost
Unrealized
Gain/Loss
Est. Annual Inc.
Yield
Onginal Cost
Accrued DIV.
US Large Cap Equity
ARIAD PHARMACEUTICALS INC
21.03
16,535.000
347,731.05
290,997.40
56,733.66
04033A-10-0 ARIA
BIOCIEN IDEC INC
166.34
2,095.000
348,482.30
250,454.95
98,027.35
09062X-10-3 BIIB
DEAN FOODS CO
16.60
25,000.000
415,000.00
470,439.75
(55,439.75)
242370-10-4 DF
FACEBOOK INC-A
27.25
17,500.000
476,875.00
665,000.00
(188,125.00)
30303M-10.2 FB
Total US Large Cap Equity
$1,588,080.35
$1,676,892.10
(348.803.75)
$0.00
0.00%
US Mid Cap Equity
P DCP MIDSTREAM PARTNERS LP
40.63
3.500.000
142,205.00
142,205.00
9.66000
6.79%
23311P-10-0 DPM
J.P.Morgan
A000unt
Page 5 of 43
Consolidated Statement Page 8
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-000 16826
SDNY_GM_00286024
EFTA01493897
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.